Bergapten

DERMATOLOGICALS

Key facts

Bergapten is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including CYP1A1, Dyrk1a and TAS2R10.

• Molecular targets: CYP1A1, Dyrk1a, TAS2R10 and MAOA (4 listed in DrugCentral).
• ATC code: D05BA03 (Psoralens for systemic use).
• Molecular formula: C12H8O4; molecular weight 216.19 g/mol.

Mechanism & targets

Molecular targets (4)

Target	Gene	Action	Activity
Cytochrome P450 1A1	CYP1A1	unknown	Ki 7.22
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Dyrk1a	unknown	AC50 5.83
Taste receptor type 2 member 10	TAS2R10	agonist	EC50 5.55
Amine oxidase [flavin-containing] A	MAOA	unknown	IC50 4.86

ATC classification

ATC code	Therapeutic hierarchy
D05BA03	DERMATOLOGICALS › ANTIPSORIATICS › ANTIPSORIATICS FOR SYSTEMIC USE › Psoralens for systemic use

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Bergapten is on its molecule page.

• Molecular formula: C₁₂H₈O₄
• Molecular weight: 216.19 g/mol
• CAS number: —
• InChIKey: BGEBZHIAGXMEMV-UHFFFAOYSA-N
• PubChem CID: 2355

COC1=C2C=COC2=CC2=C1C=CC(=O)O2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Bergapten work?

Its molecular targets in DrugCentral include CYP1A1, Dyrk1a, TAS2R10 (agonist) and MAOA.

What is the chemical formula of Bergapten?

Bergapten has the molecular formula C12H8O4 and a molecular weight of 216.19 g/mol.

Sources

• DrugCentral drug card 3021 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL24171 — compound record and bioactivity
• PubChem CID 2355 — chemical identifiers
• DrugBank DB12216 — drug record
• FDA UNII 4FVK84C92X — substance identity
• UniProt P04798 (CYP1A1) — target protein
• UniProt Q9NYW0 (TAS2R10) — target protein
• UniProt P21397 (MAOA) — target protein

How this page is built: methodology · editorial policy & corrections.